InvestorsHub Logo

dockside130

05/20/08 3:08 PM

#1116 RE: bowonwing #1115

According to information present on the introduction of this board IDM Pharma has a major product development partnership with sanofi-aventis with UVIDEM in melanoma. Medarex and sanofi-aventis are also shareholders of IDM Pharma since 1993 and 2001 respectively.

I have not seen a discussion if Sanonfi's role in this company. I will attempt to do my own dd but am interested in any knowledge that is already know to this board. I have been focused on the osteosarcoma potential only.